Investing

Proceeds from Sale of Retained Ownership Interests

Bristol-Myers Squibb Proceeds from Sale of Retained Ownership Interests increased by 2343.8% to $391.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3158.3%, from $12.00M to $391.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from Sale of Retained Ownership Interests shows a downward trend with a -58.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase signals the successful monetization of legacy financial interests, providing non-operating cash flow.

Detailed definition

Cash proceeds derived from the sale of equity stakes or ownership interests that were held in previously divested entiti...

Peer comparison

Specific to companies with complex divestiture histories and retained minority stakes.

Metric ID: ge_proceeds_from_sale_of_retained_interests

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$409.00M$244.00M$1.52B$2.00M$148.00M$63.00M$5.00M$62.00M$5.00M$148.00M$0.00$5.00M$55.00M$0.00$205.00M$12.00M$0.00$49.00M$16.00M$391.00M
QoQ Change-40.3%+523.4%-99.9%>999%-57.4%-92.1%>999%-91.9%>999%-100.0%>999%-100.0%-94.1%-100.0%-67.3%>999%
YoY Change-63.8%-74.2%-99.7%>999%-96.6%+134.9%-100.0%-91.9%>999%-100.0%+140.0%-100.0%-92.2%>999%
Range$0.00$1.52B
CAGR-0.9%
Avg YoY Growth+472.5%
Median YoY Growth-83.1%

Proceeds from Sale of Retained Ownership Interests at Other Companies

Frequently Asked Questions

What is Bristol-Myers Squibb's proceeds from sale of retained ownership interests?
Bristol-Myers Squibb (BMY) reported proceeds from sale of retained ownership interests of $391.00M in Q1 2026.
How has Bristol-Myers Squibb's proceeds from sale of retained ownership interests changed year-over-year?
Bristol-Myers Squibb's proceeds from sale of retained ownership interests increased by 3158.3% year-over-year, from $12.00M to $391.00M.
What is the long-term trend for Bristol-Myers Squibb's proceeds from sale of retained ownership interests?
Over 4 years (2021 to 2025), Bristol-Myers Squibb's proceeds from sale of retained ownership interests has grown at a -58.4% compound annual growth rate (CAGR), from $2.58B to $77.00M.
What does proceeds from sale of retained ownership interests mean?
Cash received from selling remaining ownership stakes in previously sold businesses.